SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Maternal-Fetal Medicine Consultation — Mumtaz Mahal — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Mumtaz Mahal |
|---|
| Date of birth | 1593-04-27 |
|---|
| Identifiers | MRN HR-RE006-SYN-TD; SSN (made up) 000-06-7184 |
|---|
| Document date | 1631-02-03 |
|---|
| Author | Adaeze Montgomery-Rahimi, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Fourteenth pregnancy at 37, at 13 weeks 2 days by today's scan, conceived about five and a half months after her last birth, with iron deficiency anemia. Please advise on surveillance, anemia treatment, placental assessment, the timing and place of birth, and planning to prevent postpartum hemorrhage. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- What surveillance does this pregnancy need, given her age, grand multiparity, and the short interval since her last birth?
- How should her iron deficiency anemia be treated, and when should we move to intravenous iron?
- How should the placenta be assessed for previa and accreta after thirteen births?
- When and where should she give birth, and should labor be induced?
- What should the postpartum hemorrhage prevention and treatment plan include?
- What advice should she have about travel during this pregnancy?
- When and how should contraception and the interval before any future pregnancy be discussed?
History of Present Illness
Mumtaz Mahal is seen at the request of Dr. Qureshi-Lindholm at 17 weeks 2 days. She has had thirteen vaginal births, all by her account at or near term, with labors that were often short, and no cesarean, uterine surgery, or blood transfusion; she does not know of heavy bleeding after any birth. One baby died soon after birth, and five other children died in infancy or early childhood. This pregnancy began about five and a half months after her last birth. She has taken about half of her oral iron doses because of nausea and constipation and remains tired. She has no bleeding, pain, or urinary symptoms and has felt the first movements. She travels often with her family and expects to travel again in the spring. She wants clear plans and prefers women clinicians. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- She was born Arjumand Banu Begum in Agra in April 1593; an encyclopedia, citing a seventeenth-century court history, gives 27 April 1593. [D]
- Her father, Abu'l-Hasan Asaf Khan, was a Persian noble; his sister was the Empress Nur Jahan, wife of the emperor Jahangir. Her mother's family came from Qazvin in Persia. [D]
- She was betrothed to Prince Khurram, later the emperor Shah Jahan, in 1607, and married him on 10 May 1612; he gave her the title Mumtaz Mahal, rendered as 'Chosen One of the Palace' or 'the Exalted One of the Palace'. [D]
- She was a Shi'a Muslim. [D]
- Despite her frequent pregnancies, she travelled with her husband's entourage on his military campaigns. [D]
- Her first thirteen children were born between 1613 and 1630: Hur-ul-Nisa (1613), Jahanara (1614), Dara Shikoh (1615), Shah Shuja (1616), Roshanara (1617), Aurangzeb (1618), Izad Bakhsh (1619), Surayya Banu (1621), a son who died soon after birth (1622), Murad Bakhsh (1624), Lutf Allah (1626), Daulat Afza (1628), and Husn Ara (1630). [D]
- Six of her children died in infancy or early childhood before 1631: Hur-ul-Nisa at three and Surayya Banu at seven, both of smallpox; Izad Bakhsh in infancy; a son soon after birth in 1622; Lutf Allah at about eighteen months; and Daulat Afza in infancy. [D]
- Her thirteenth child, Husn Ara, was born on 23 April 1630. [D]
- In the year 1040 AH (from August 1630) the emperor was in the Deccan with the court at Burhanpur, during a severe famine in the Deccan and Gujarat, when he ordered soup kitchens and weekly alms for as long as he remained at Burhanpur. [D]
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1631-01-06 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea and calcium | Oral route | 1631-01-06 to 1631-02-03 | completed | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime | One tablet by mouth at bedtime until delivery | Oral route | 1631-01-06 | active | S |
| Ferric carboxymaltose 750 mg in 250 mL 0.9% sodium chloride, intravenous infusion over 15 minutes (first of two doses) | Single infusion; two doses in total, four weeks apart | Intravenous route | 1631-02-03 to 1631-02-03 | completed | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Fourteenth pregnancy at 37 (gravida 14, para 13), single live intrauterine pregnancy dated by ultrasound at 13 weeks 2 days; estimated due date July 12 | active | confirmed |
O09.529 | S — Synthetic modern prenatal care anchored to her documented fourteenth pregnancy; the dates are synthetic. |
| Grand multiparity: thirteen previous vaginal births, no cesarean or other uterine surgery; seven living children | active | confirmed |
O09.40 | S — Synthetic modern problem anchored to her documented thirteen earlier births. |
| Short interpregnancy interval: conception about five and a half months after her last birth | active | confirmed |
O09.899 | S — Synthetic modern problem anchored to the documented fourteen months between her last two births. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mL | active | confirmed |
O99.019 | S — Synthetic finding; repeated pregnancies close together deplete iron. It echoes no documented diagnosis. |
Physical Exam
Vital signs recorded on 1631-02-03; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well; pale conjunctivae |
| Abdomen | Uterus consistent with 17 weeks; non-tender; no scars |
| Fetal | Fetal heart 152 per minute |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1631-02-03 | Hemoglobin [Mass/volume] in Blood | 10.3 | g/dL | 10.5-15 g/dL | Low | S |
| 1631-02-03 | Ferritin [Mass/volume] in Serum or Plasma | 12 | ng/mL | 30-150 ng/mL | Low | S |
Assessment
- Fourteenth pregnancy at 37 (O09.529). A singleton pregnancy at an advanced maternal age with a low-risk aneuploidy screen. Age 35 or older raises the risks of preeclampsia, gestational diabetes, fetal growth restriction, and stillbirth; aspirin is correctly started. [S]
- Grand multiparity (O09.40). Thirteen previous births raise the risks of uterine atony and postpartum hemorrhage, malpresentation, and fast labor. Without a uterine scar, the risk of placenta accreta spectrum is low unless the placenta lies over the cervix. [S]
- Short interpregnancy interval (O09.899). An interval under six months from birth to conception is linked to anemia, preterm birth, and a small baby. [S]
- Iron deficiency anemia in pregnancy (O99.019). Iron deficiency anemia that has not responded to oral iron, which she cannot tolerate; thalassemia trait excluded. Anemia at delivery would leave her little reserve if she bleeds. [S]
Data reviewed: The dating and nuchal translucency scan; cell-free DNA (low risk); blood group O RhD positive with a negative antibody screen; rubella immune; hepatitis B, HIV, syphilis, and hepatitis C negative; urine culture no growth; hemoglobin electrophoresis normal; hemoglobin 10.1 g/dL with ferritin 9 ng/mL at intake and 10.3 g/dL with ferritin 12 ng/mL today; hemoglobin A1c 5.4 percent; today's vital signs (blood pressure 106/64 mmHg, weight 59.8 kg). [S]
Plan of Treatment
- Intravenous iron now that she is in the second trimester: ferric carboxymaltose 750 mg today and again in four weeks, with hemoglobin and ferritin before each dose and at 24 to 28 weeks; aim for a hemoglobin of at least 11 g/dL before delivery. [S]
- Detailed anatomy scan at 20 to 22 weeks with placental location; if the placenta is low-lying or over the cervix, repeat at 32 weeks and assess for accreta; otherwise no MRI is needed. [S]
- Continue aspirin 81 mg nightly until delivery; blood pressure and urine protein at every visit; glucose challenge at 24 to 28 weeks; visits every two weeks from 28 weeks and weekly from 36 weeks; a growth scan at 32 to 34 weeks; weekly fetal heart rate monitoring from 36 weeks can be offered. [S]
- Birth in a hospital with a blood bank, 24-hour anesthesia, and an operating theatre; offer induction at 39 weeks, which also avoids an unplanned birth away from the hospital. [S]
- Postpartum hemorrhage plan, written by 36 weeks: risk assessment on admission, type and screen, two large-bore lines, oxytocin 10 units at birth with controlled cord traction, quantitative blood loss, and, if hemorrhage occurs, tranexamic acid 1 g intravenously within 3 hours of birth with a second dose after 30 minutes if bleeding continues, alongside uterotonics, uterine massage, and the hemorrhage protocol; anesthesia consultation at 36 weeks. [S]
- Travel is reasonable in the second trimester and early third trimester if she stays well: carry her records, keep her prenatal visits where she stays, walk and drink often on long journeys, and stay near the delivery hospital from 36 weeks. [S]
- Discuss postpartum contraception and the interval before any future pregnancy in the third trimester, in her own terms; advise waiting at least 18 months, ideally 24, after this birth. [S]
- Discussed with Dr. Qureshi-Lindholm the same day; Mumtaz Mahal agrees with the plan, and the first iron infusion is given today. [S]
- Follow-up: Primary obstetric care continues with Dr. Qureshi-Lindholm. Maternal-fetal medicine will review the anatomy scan and see her again if any problem arises, and in any case before the birth. [S]